HR 5031
107th Congress
House
Health
Agriculture and Food
Ambulatory care
Animal genetics
Animals
Clinical trials
Congress
Congressional investigations
Congressional reporting requirements
Department of Health and Human Services
Digestive diseases
Drug therapy
Education
Environmental Protection
Environmental health
Epidemiology
Genetic research
Government Operations and Politics
Governmental investigations
Health education
Inflammatory Bowel Disease Act
Introduced: June 27, 2002
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 16, 2002
Referred to the Subcommittee on Health.
Jun 27, 2002
Referred to the House Committee on Energy and Commerce.
Jun 27, 2002
Introduced in House
Plain-English summary
Inflammatory Bowel Disease Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand activities addressing inflammatory bowel disease, emphasizing genetic, animal model, and clinical research.
Requires the Director of the Centers for Disease Control and Prevention to establish a national program of prevention and epidemiology concerning such disease, addressing its prevalence and public and professional awareness.
Directs the Institute of Medicine of the National Academies of Science to study public and private insurance standards for coverage of inflammatory bowel therapies.
Directs the General Accounting Office to study problems inflammatory bowel disease patients have applying for disability insurance benefits under the Social Security Act.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2